Cargando…

Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds

BACKGROUND: The current standard care therapy for hepatitis C virus (HCV) infection consists of two regimes, namely interferon-based and interferon-free treatments. The treatment through the combination of ribavirin and pegylated interferon is expensive, only mildly effective, and is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathew, Shilu, Fatima, Kaneez, Fatmi, M. Qaiser, Archunan, Govindaraju, Ilyas, Muhammad, Begum, Nargis, Azhar, Esam, Damanhouri, Ghazi, Qadri, Ishtiaq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451521/ https://www.ncbi.nlm.nih.gov/pubmed/26030803 http://dx.doi.org/10.1371/journal.pone.0126510

Ejemplares similares

Comparison of Structural Architecture of HCV NS3 Genotype 1 versus Pakistani Genotype 3a
por: Fatima, Kaneez, et al.
Publicado: (2014)

Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target
por: Fatima, Kaneez, et al.
Publicado: (2014)

In Silico Studies of Medicinal Compounds Against Hepatitis C Capsid Protein from North India
por: Mathew, Shilu, et al.
Publicado: (2014)

Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a
por: Manzoor, Sobia, et al.
Publicado: (2011)

Oxidative stress and hepatitis C virus
por: Paracha, Usman Zafar, et al.
Publicado: (2013)

Unraveling the Complex Relationship Triad between Lipids, Obesity, and Inflammation
por: Khan, Shahida A., et al.
Publicado: (2014)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)

Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH
por: Qadri, Ishtiaq, et al.
Publicado: (2011)

Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients
por: Salahuddin, Sadia, et al.
Publicado: (2018)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

“Stay in touch while on the bench” - how the MIQE applet can increase the quality of your qPCR and dPCR experiments
por: Abdel Nour, Afif M, et al.
Publicado: (2014)

Five Years MIQE Guidelines: The Case of the Arabian Countries
por: Abdel Nour, Afif M., et al.
Publicado: (2014)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

HCV genotypes distribution pattern in India
por: Bokharaei-Salim, Farah, et al.
Publicado: (2012)

Prevalence of HCV genotypes in district Mardan
por: Afridi, Suliman Qadir, et al.
Publicado: (2013)

HCV Detection, Discrimination, and Genotyping Technologies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2018)

Tackling dengue fever: Current status and challenges
por: Nedjadi, Taoufik, et al.
Publicado: (2015)

HCV Genotyping from NGS Short Reads and Its Application in Genotype Detection from HCV Mixed Infected Plasma
por: Qiu, Ping, et al.
Publicado: (2015)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

HCV genotyping using statistical classification approach
por: Qiu, Ping, et al.
Publicado: (2009)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
por: Ahmad, Waqar, et al.
Publicado: (2011)

Genotyping of HCV RNA Reveals That 3a Is the Most Prevalent Genotype in Mardan, Pakistan
por: Ali, Sajid, et al.
Publicado: (2014)

Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance
por: Parvaiz, Fahed, et al.
Publicado: (2011)

Odorant Binding Proteins: a key player in the sense of smell
por: Archunan, Govindaraju
Publicado: (2018)

Discovery of Klotho peptide antagonists against Wnt3 and Wnt3a target proteins using combination of protein engineering, protein–protein docking, peptide docking and molecular dynamics simulations
por: Mirza, Shaher Bano, et al.
Publicado: (2016)

Evaluating the binding efficiency of pheromone binding protein with its natural ligand using molecular docking and fluorescence analysis
por: Ilayaraja, Renganathan, et al.
Publicado: (2014)

Evaluation of the Abbott Real Time HCV genotype II assay for Hepatitis C virus genotyping
por: Sariguzel, Fatma Mutlu, et al.
Publicado: (2015)

Prevalence and Genotyping of High Risk Human Papillomavirus in Cervical Cancer Samples from Punjab, Pakistan
por: Siddiqa, Abida, et al.
Publicado: (2014)

HCV Genotypes of People with Hemophilia in Countries with High Seroprevalances
por: Mahlangu, J N, et al.
Publicado: (2011)

Genotyping Pattern among Iranian HCV Positive Patients
por: Hajia, M, et al.
Publicado: (2010)

Genotypic resistance testing of HCV – is there a clinical need?
por: Walker, Andreas, et al.
Publicado: (2016)

Distribution of HCV genotypes in Belgium from 2008 to 2015
por: Bouacida, Lobna, et al.
Publicado: (2018)

Prevalence of HCV genotypes in Poland – the EpiTer study
por: Flisiak, Robert, et al.
Publicado: (2016)

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
por: Sarwar, Muhammad T, et al.
Publicado: (2011)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
por: Ali, Amjad, et al.
Publicado: (2011)

Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells
por: Subramani, Murali, et al.
Publicado: (2017)

In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds
por: Mathew, Shilu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ocfn39748q0icjkpp2deql3e4